INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

NERVMinerva Neurosciences, Inc.

CIK 0001598646

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score9
Connections3with evidence

NERV · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
2,328 sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    O'Connor James JosephChief Business Officer and GC · Apr 22, 2026
  • ← Insider ofevidence
    Kaul InderjitDirector · Nov 18, 2025
9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A
—
50.0K sh
Jun 3, 2026
Jun 5, 2026
traded Jun 3, 2026
+2d
SEC FORM 4

Evidence

9
OJ
O'Connor James JosephChief Business Officer and GC
NERVMinerva Neurosciences, Inc.
Grant or award
A—
350.8K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC FORM 4

Evidence

9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
12.2K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
364.5K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
9,500 sh
Nov 14, 2025Nov 18, 2025
traded Nov 14, 2025
+4dSEC FORM 4

Evidence